Iperplasia prostatica benigna (Italian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Iperplasia prostatica benigna" in Italian language version.

refsWebsite

Global rank Italian rank

17nih.gov

4^th place

9^th place

12doi.org

2^nd place

7^th place

5oadoi.org

799^th place

22^nd place

1humanitas.it

low place

3,217^th place

1who.int

195^th place

342^nd place

1worldcat.org

5^th place

26^th place

1minervamedica.it

low place

9,617^th place

1biomedcentral.com

2,747^th place

1,948^th place

1web.archive.org

1^st place

biomedcentral.com

Iacono F, Prezioso D, Di Lauro G, Romeo G, Ruffo A, Illiano E, Amato B, Efficacy and safety profile of a novel technique, ThuLEP (Thulium laser enucleation of the prostate) for the treatment of benign prostate hypertrophy. Our experience on 148 patients, in BMC Surg, 12 Suppl 1, 2012, pp. S21, DOI:10.1186/1471-2482-12-S1-S21, PMC 3499280, PMID 23173611.

doi.org

dx.doi.org

Theo Vos, Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010, in The Lancet, vol. 380, n. 9859, 1º dicembre 2012, pp. 2163–2196, DOI:10.1016/S0140-6736(12)61729-2, PMID 23245607.
K Verhamme, JP Dieleman, GS Bleumink, J Van Der Lei, MC Sturkenboom, W Artibani, B Begaud, R Berges, A Borkowski, C. R. Chappel, A Costello, P Dobronski, R. D. Farmer, F Jiménez Cruz, U Jonas, K MacRae, L Pientka, F. F. Rutten, C. P. Van Schayck, M. J. Speakman, M. C. Sturkenboom, P Tiellac, A Tubaro, G Vallencien, R Vela Navarrete e Triumph Pan European Expert Panel, Incidence and Prevalence of Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia in Primary Care—The Triumph Project, in European Urology, vol. 42, n. 4, 2002, pp. 323–8, DOI:10.1016/S0302-2838(02)00354-8, PMID 12361895.
D. Barone, F. Peroglio; E. Toso; T. Bruzzese, Binding of mepartricin to sex hormones, a key factor of its activity on benign prostatic hyperplasia., in Arzneimittelforschung, vol. 51, n. 12, 2001, pp. 984-90, DOI:10.1055/s-0031-1300149, PMID 11799846.
A. Keehn, J. Taylor; FC. Lowe, Phytotherapy for Benign Prostatic Hyperplasia., in Curr Urol Rep, vol. 17, n. 7, Jul 2016, p. 53, DOI:10.1007/s11934-016-0609-z, PMID 27180172.
Emilio Sacco, Riccardo Bientinesi, Francesco Marangi, Angelo Totaro, Alessandro D'Addessi, Marco Racioppi, Francesco Pinto, Matteo Vittori e Pierfrancesco Bassi, Patient-reported outcomes in men with lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH) treated with intraprostatic OnabotulinumtoxinA: 3-month results of a prospective single-armed cohort study: PROs IN MEN WITH LUTS TREATED WITH INTRAPROSTATIC BTX-A, in BJU International, vol. 110, 11c, --, pp. E837–E844, DOI:10.1111/j.1464-410X.2012.11288.x.
Barski D, Richter M, Winter C, Arsov C, de Geeter P, Rabenalt R, Albers P, Holmium laser ablation of the prostate (HoLAP): intermediate-term results of 144 patients, in World J Urol, vol. 31, n. 5, 2013, pp. 1253–9, DOI:10.1007/s00345-012-0901-6, PMID 22782618.
Herrmann TR, Bach T, Imkamp F, Georgiou A, Burchardt M, Oelke M, Gross AJ, Thulium laser enucleation of the prostate (ThuLEP): transurethral anatomical prostatectomy with laser support. Introduction of a novel technique for the treatment of benign prostatic obstruction, in World J Urol, vol. 28, n. 1, 2010, pp. 45–51, DOI:10.1007/s00345-009-0503-0, PMID 20063164.
Iacono F, Prezioso D, Di Lauro G, Romeo G, Ruffo A, Illiano E, Amato B, Efficacy and safety profile of a novel technique, ThuLEP (Thulium laser enucleation of the prostate) for the treatment of benign prostate hypertrophy. Our experience on 148 patients, in BMC Surg, 12 Suppl 1, 2012, pp. S21, DOI:10.1186/1471-2482-12-S1-S21, PMC 3499280, PMID 23173611.
Kuang M, Vu A, Athreya S, A systematic review of prostatic artery embolization in the treatment of symptomatic benign prostatic hyperplasia., in Cardiovasc Intervent Radiol, vol. 40, n. 5, 2017, pp. 655-663, DOI:10.1007/s00270-016-1539-3, PMID 28032133.
Pisco J, Bilhim T, Pinheiro LC, Fernandes L, Pereira J, Costa NV, Duarte M, Oliveira AG, Prostate embolization as an alternative to open surgery in patients with large prostate and moderate to severe lower urinary tract symptoms., in J Vasc Interv Radiol, vol. 27, n. 5, 2016, pp. 700-8, DOI:10.1016/j.jvir.2016.01.138, PMID 27019980.

doi.org

Kuang M, Vu A, Athreya S, A systematic review of prostatic artery embolization in the treatment of symptomatic benign prostatic hyperplasia., in Cardiovasc Intervent Radiol, vol. 40, n. 5, 2017, pp. 655-663, DOI:10.1007/s00270-016-1539-3, PMID 28032133.
Pisco J, Bilhim T, Pinheiro LC, Fernandes L, Pereira J, Costa NV, Duarte M, Oliveira AG, Prostate embolization as an alternative to open surgery in patients with large prostate and moderate to severe lower urinary tract symptoms., in J Vasc Interv Radiol, vol. 27, n. 5, 2016, pp. 700-8, DOI:10.1016/j.jvir.2016.01.138, PMID 27019980.

humanitas.it

Iperplasia prostatica benigna, su Humanitas. URL consultato il 26 agosto 2023.

minervamedica.it

Herrmann TR, Georgiou A, Bach T, Gross AJ, Oelke M, Laser treatments of the prostate vs TURP/ open prostatectomy: systematic review of urodynamic data, in Minerva Urol Nefrol, vol. 61, n. 3, 2009, pp. 309–24, PMID 19773731.

nih.gov

ncbi.nlm.nih.gov

Theo Vos, Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010, in The Lancet, vol. 380, n. 9859, 1º dicembre 2012, pp. 2163–2196, DOI:10.1016/S0140-6736(12)61729-2, PMID 23245607.
K Verhamme, JP Dieleman, GS Bleumink, J Van Der Lei, MC Sturkenboom, W Artibani, B Begaud, R Berges, A Borkowski, C. R. Chappel, A Costello, P Dobronski, R. D. Farmer, F Jiménez Cruz, U Jonas, K MacRae, L Pientka, F. F. Rutten, C. P. Van Schayck, M. J. Speakman, M. C. Sturkenboom, P Tiellac, A Tubaro, G Vallencien, R Vela Navarrete e Triumph Pan European Expert Panel, Incidence and Prevalence of Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia in Primary Care—The Triumph Project, in European Urology, vol. 42, n. 4, 2002, pp. 323–8, DOI:10.1016/S0302-2838(02)00354-8, PMID 12361895.
Barry MJ, Fowler FJ Jr, O'Leary MP, et al (1992). The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association. J Urol 148(5): 1549-57. PMID 1279218
AUA Practice Guidelines Committee. AUA guideline on management of benign prostatic hyperplasia (2003). Chapter 1: Diagnosis and treatment recommendations. J Urol, 170(2 Pt 1): 530-47. PMID 12853821
Kaplan SA, McConnell JD, Roehrborn CG, et al (2006). Combination therapy with doxazosin and finasteride for benign prostatic hyperplasia in patients with lower urinary tract symptoms and a baseline total prostate volume of 25 ml or greater. J Urol, 175(1): 217-20. PMID 16406915.
McVary KT, Monnig W, Camps JL Jr, et al (2007). Sildenafil citrate improves erectile function and urinary symptoms in men with erectile dysfunction and lower urinary tract symptoms associated with benign prostatic hyperplasia: a randomized, double-blind trial. J Urol, 177(3) :1071-7. PMID 17296414
V. Mirone, D. Prezioso; A. Palmieri; P. Bocchini, Therapeutic usefulness of mepartricin in benign prostatic hypertrophy: 2 years' experience. Preliminary note on the effect of mepartricin on certain possible etiopathogenic factors in benign prostatic hypertrophy., in Minerva Urol Nefrol, vol. 40, 2 Suppl, pp. 16-7, PMID 2460938.
S. Boehm, G. Nirnberger; P. Ferrari, Estrogen suppression as a pharmacotherapeutic strategy in the medical treatment of benign prostatic hyperplasia: evidence for its efficacy from studies with mepartricin., in Wien Klin Wochenschr, vol. 110, n. 23, Dec 1998, pp. 817-23, PMID 10025034.
D. Barone, F. Peroglio; E. Toso; T. Bruzzese, Binding of mepartricin to sex hormones, a key factor of its activity on benign prostatic hyperplasia., in Arzneimittelforschung, vol. 51, n. 12, 2001, pp. 984-90, DOI:10.1055/s-0031-1300149, PMID 11799846.
A. Keehn, J. Taylor; FC. Lowe, Phytotherapy for Benign Prostatic Hyperplasia., in Curr Urol Rep, vol. 17, n. 7, Jul 2016, p. 53, DOI:10.1007/s11934-016-0609-z, PMID 27180172.
Herrmann TR, Georgiou A, Bach T, Gross AJ, Oelke M, Laser treatments of the prostate vs TURP/ open prostatectomy: systematic review of urodynamic data, in Minerva Urol Nefrol, vol. 61, n. 3, 2009, pp. 309–24, PMID 19773731.
Te AE, Malloy TR, Stein BS, Ulchaker JC, Nseyo UO, Hai MA, Malek RS, Photoselective vaporization of the prostate for the treatment of benign prostatic hyperplasia: 12-month results from the first United States multicenter prospective trial, in J. Urol., vol. 172, 4 Pt 1, 2004, pp. 1404–8, PMID 15371855.
Barski D, Richter M, Winter C, Arsov C, de Geeter P, Rabenalt R, Albers P, Holmium laser ablation of the prostate (HoLAP): intermediate-term results of 144 patients, in World J Urol, vol. 31, n. 5, 2013, pp. 1253–9, DOI:10.1007/s00345-012-0901-6, PMID 22782618.
Herrmann TR, Bach T, Imkamp F, Georgiou A, Burchardt M, Oelke M, Gross AJ, Thulium laser enucleation of the prostate (ThuLEP): transurethral anatomical prostatectomy with laser support. Introduction of a novel technique for the treatment of benign prostatic obstruction, in World J Urol, vol. 28, n. 1, 2010, pp. 45–51, DOI:10.1007/s00345-009-0503-0, PMID 20063164.
Iacono F, Prezioso D, Di Lauro G, Romeo G, Ruffo A, Illiano E, Amato B, Efficacy and safety profile of a novel technique, ThuLEP (Thulium laser enucleation of the prostate) for the treatment of benign prostate hypertrophy. Our experience on 148 patients, in BMC Surg, 12 Suppl 1, 2012, pp. S21, DOI:10.1186/1471-2482-12-S1-S21, PMC 3499280, PMID 23173611.
Kuang M, Vu A, Athreya S, A systematic review of prostatic artery embolization in the treatment of symptomatic benign prostatic hyperplasia., in Cardiovasc Intervent Radiol, vol. 40, n. 5, 2017, pp. 655-663, DOI:10.1007/s00270-016-1539-3, PMID 28032133.
Pisco J, Bilhim T, Pinheiro LC, Fernandes L, Pereira J, Costa NV, Duarte M, Oliveira AG, Prostate embolization as an alternative to open surgery in patients with large prostate and moderate to severe lower urinary tract symptoms., in J Vasc Interv Radiol, vol. 27, n. 5, 2016, pp. 700-8, DOI:10.1016/j.jvir.2016.01.138, PMID 27019980.

oadoi.org

Theo Vos, Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010, in The Lancet, vol. 380, n. 9859, 1º dicembre 2012, pp. 2163–2196, DOI:10.1016/S0140-6736(12)61729-2, PMID 23245607.
K Verhamme, JP Dieleman, GS Bleumink, J Van Der Lei, MC Sturkenboom, W Artibani, B Begaud, R Berges, A Borkowski, C. R. Chappel, A Costello, P Dobronski, R. D. Farmer, F Jiménez Cruz, U Jonas, K MacRae, L Pientka, F. F. Rutten, C. P. Van Schayck, M. J. Speakman, M. C. Sturkenboom, P Tiellac, A Tubaro, G Vallencien, R Vela Navarrete e Triumph Pan European Expert Panel, Incidence and Prevalence of Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia in Primary Care—The Triumph Project, in European Urology, vol. 42, n. 4, 2002, pp. 323–8, DOI:10.1016/S0302-2838(02)00354-8, PMID 12361895.
D. Barone, F. Peroglio; E. Toso; T. Bruzzese, Binding of mepartricin to sex hormones, a key factor of its activity on benign prostatic hyperplasia., in Arzneimittelforschung, vol. 51, n. 12, 2001, pp. 984-90, DOI:10.1055/s-0031-1300149, PMID 11799846.
A. Keehn, J. Taylor; FC. Lowe, Phytotherapy for Benign Prostatic Hyperplasia., in Curr Urol Rep, vol. 17, n. 7, Jul 2016, p. 53, DOI:10.1007/s11934-016-0609-z, PMID 27180172.
Emilio Sacco, Riccardo Bientinesi, Francesco Marangi, Angelo Totaro, Alessandro D'Addessi, Marco Racioppi, Francesco Pinto, Matteo Vittori e Pierfrancesco Bassi, Patient-reported outcomes in men with lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH) treated with intraprostatic OnabotulinumtoxinA: 3-month results of a prospective single-armed cohort study: PROs IN MEN WITH LUTS TREATED WITH INTRAPROSTATIC BTX-A, in BJU International, vol. 110, 11c, --, pp. E837–E844, DOI:10.1111/j.1464-410X.2012.11288.x.

web.archive.org

Pharmamedix: Ipertrofia prostatica (IPB), su pharmamedix.com. URL consultato il 22 marzo 2011 (archiviato dall'url originale il 24 aprile 2013).

who.int

WHO Disease and injury country estimates, su World Health Organization, 2009. URL consultato l'11 novembre 2009.

worldcat.org

LOWER URINARY TRACT SYMPTOMS AND BENIGN PROSTATIC HYPERPLASIA : from., ELSEVIER ACADEMIC PRESS, 2018, ISBN 978-0-12-811397-4, OCLC 993645266.